Get the Stockscreener App
0.3703
1.81%
0.0066
Pre-market:
.37
-0.0003
-0.08%
Immutep Limited Adr stock is traded at $0.3703, with a volume of 219.67K.
It is up +1.81% in the last 24 hours and down -28.75% over the past month.
Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.
See More
Previous Close:
$0.3637
Open:
$0.355
24h Volume:
219.67K
Relative Volume:
0.02
Market Cap:
$54.57M
Revenue:
-
Net Income/Loss:
$-54.17M
P/E Ratio:
-1.0011
EPS:
-0.3699
Net Cash Flow:
$-39.34M
1W Performance:
+0.38%
1M Performance:
-28.75%
6M Performance:
-84.82%
1Y Performance:
-78.72%
1-Day Range:
$0.355
$0.3869
1-Week Range:
$0.3465
$0.3869
52-Week Range:
$0.2928
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Compare IMMP vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.3703 | 54.57M | 0 | -54.17M | -39.34M | -0.3699 |
VRTX
Vertex Pharmaceuticals Inc
|
450.46 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.98 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.20 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.80 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
160.06 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-26 | Downgrade | Citizens | Mkt Outperform → Mkt Perform |
| Mar-13-26 | Downgrade | Maxim Group | Buy → Hold |
| Mar-13-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-17-26 | Initiated | Citizens | Mkt Outperform |
| May-17-24 | Initiated | CapitalOne | Overweight |
| Aug-03-23 | Initiated | Robert W. Baird | Outperform |
| Aug-03-21 | Initiated | Ladenburg Thalmann | Buy |
| Jul-16-21 | Resumed | Maxim Group | Buy |
| Sep-28-18 | Initiated | B. Riley FBR | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
View All
Immutep Limited Adr Stock (IMMP) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
IMMP Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
IMM:ASX AnnouncementChange in substantial holding09 Jun 2026 - Market Index
IMMP UPCOMING DEADLINE: Levi & Korsinsky Alerts Immutep Limited Stockholders of Securities Class Action - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
רוזן, יועץ למשקיעים מוביל, מעודד את משקיעי Immutep Ltd. לקבל ייעוץ משפטי לפני מועד אחרון חשוב בתביעה ייצוגית לניירות ערך - GlobeNewswire Inc.
IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit - Morningstar
IMMP Shareholder Alert: Immutep Limited Securities Class Action LawsuitInvestors Should Contact SueWallSt - Sahm
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm - Barchart
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - TMX Newsfile
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel ... - Caledonian Record
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026IMMP - Barchart
ROSEN, A RANKED AND LEADING FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, A RANKED AND LEADING FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
IMMP Shareholder Alert: July 6, 2026 Lead Plaintiff Deadline in Immutep Limited Securities Class ActionContact The Gross Law Firm - Barchart.com
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Pomerantz LLP Highlights Legal Filing Against Immutep Limited – IMMP - ACCESS Newswire
Lost Money on Immutep Limited (IMMP)? Join Class Action Suit Seeking RecoveryContact SueWallSt - Barchart
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming DeadlinesIMMP - PR Newswire
Pomerantz LLP Highlights Class Action Against Immutep Limited – IMMP - ACCESS Newswire
IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - Morningstar
FinancialContentINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP - FinancialContent
Pomerantz LLP Calls Attention to Class Action Involving Immutep Limited – IMMP - ACCESS Newswire
IMMP INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - ChartMill
IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP | FinancialContent - FinancialContent
ROSEN, A TOP RANKED LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - Lelezard
Rosen Law Firm Investigates Immutep Securities Fraud Claims - Intellectia AI
IMMP Class Action Reminder - GlobeNewswire Inc.
IMMP Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Immutep Limited - Barchart.com
Rosen Law Firm Urges Immutep Ltd. (NASDAQ: IMMP) Stockholders to - The National Law Review
Rosen Law Firm Urges Immutep Ltd. (NASDAQ: IMMP) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep - GlobeNewswire
Immutep Limited Adr Stock (IMMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):